139 related articles for article (PubMed ID: 38524208)
1. Oocyte cryopreservation and reciprocal in vitro fertilization in a transgender man on long term testosterone gender-affirming hormone therapy: a case report.
White J; Jackson A; Druce I; Gale J
F S Rep; 2024 Mar; 5(1):111-113. PubMed ID: 38524208
[TBL] [Abstract][Full Text] [Related]
2. Fertility treatment outcomes in transgender men with a history of testosterone therapy.
Ghofranian A; Estevez SL; Gellman C; Gounko D; Lee JA; Thornton K; Copperman AB
F S Rep; 2023 Dec; 4(4):367-374. PubMed ID: 38204952
[TBL] [Abstract][Full Text] [Related]
3. Oocyte cryopreservation in a transgender man on long-term testosterone therapy: a case report.
Gale J; Magee B; Forsyth-Greig A; Visram H; Jackson A
F S Rep; 2021 Jun; 2(2):249-251. PubMed ID: 34278362
[TBL] [Abstract][Full Text] [Related]
4. Successful In Vitro Fertilization in a Cisgender Female Carrier Using Oocytes Retrieved From a Transgender Man Maintained on Testosterone.
Greenwald P; Dubois B; Lekovich J; Pang JH; Safer J
AACE Clin Case Rep; 2022; 8(1):19-21. PubMed ID: 35097196
[TBL] [Abstract][Full Text] [Related]
5. Fertility preservation in a transgender man without prolonged discontinuation of testosterone: a case report and literature review.
Cho K; Harjee R; Roberts J; Dunne C
F S Rep; 2020 Jun; 1(1):43-47. PubMed ID: 34223211
[TBL] [Abstract][Full Text] [Related]
6. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation in transgender men without discontinuation of testosterone.
Stark BA; Mok-Lin E
F S Rep; 2022 Jun; 3(2):153-156. PubMed ID: 35789719
[TBL] [Abstract][Full Text] [Related]
8. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
[TBL] [Abstract][Full Text] [Related]
9. Impaired in vitro fertilization outcomes following testosterone treatment improve with washout in a mouse model of gender-affirming hormone treatment.
Schwartz AR; Xu M; Henderson NC; Dela Cruz C; Pfau D; Padmanabhan V; Shikanov A; Moravek MB
Am J Obstet Gynecol; 2023 Oct; 229(4):419.e1-419.e10. PubMed ID: 37453652
[TBL] [Abstract][Full Text] [Related]
10. Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men.
Lierman S; Tolpe A; De Croo I; De Gheselle S; Defreyne J; Baetens M; Dheedene A; Colman R; Menten B; T'Sjoen G; De Sutter P; Tilleman K
Fertil Steril; 2021 Oct; 116(4):1068-1076. PubMed ID: 33832736
[TBL] [Abstract][Full Text] [Related]
11. Fertility Preservation for Adolescent and Young Adult Transmen: A Case Series and Insights on Oocyte Cryopreservation.
Barrett F; Shaw J; Blakemore JK; Fino ME
Front Endocrinol (Lausanne); 2022; 13():873508. PubMed ID: 35685214
[TBL] [Abstract][Full Text] [Related]
12. Ovarian stimulation outcomes among transgender men compared with fertile cisgender women.
Amir H; Yaish I; Samara N; Hasson J; Groutz A; Azem F
J Assist Reprod Genet; 2020 Oct; 37(10):2463-2472. PubMed ID: 32719977
[TBL] [Abstract][Full Text] [Related]
13. [Clinical effects of oocyte cryopreservation in assisted reproduction technology].
Wang W; Yan ZJ; Cai LB; Chai DC; Liu CZ; Mao YD; Liu JY
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2755-8. PubMed ID: 19080449
[TBL] [Abstract][Full Text] [Related]
14. Characterization of ovarian tissue oocytes from transgender men reveals poor calcium release and embryo development, which might be overcome by spindle transfer.
Christodoulaki A; He H; Zhou M; Cardona Barberán A; De Roo C; Chuva De Sousa Lopes SM; Baetens M; Menten B; Van Soom A; De Sutter P; Weyers S; Boel A; Stoop D; Heindryckx B
Hum Reprod; 2023 Jun; 38(6):1135-1150. PubMed ID: 37029914
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of oocyte cryopreservation: a meta-analysis.
Oktay K; Cil AP; Bang H
Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
[TBL] [Abstract][Full Text] [Related]
16. Birth after cryopreservation of immature oocytes with subsequent in vitro maturation.
Tucker MJ; Wright G; Morton PC; Massey JB
Fertil Steril; 1998 Sep; 70(3):578-9. PubMed ID: 9757897
[TBL] [Abstract][Full Text] [Related]
17. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients.
Grifo JA; Noyes N
Fertil Steril; 2010 Feb; 93(2):391-6. PubMed ID: 19439285
[TBL] [Abstract][Full Text] [Related]
18. A 10-year follow-up of reproductive outcomes in women attempting motherhood after elective oocyte cryopreservation.
Loreti S; Darici E; Nekkebroeck J; Drakopoulos P; Van Landuyt L; De Munck N; Tournaye H; De Vos M
Hum Reprod; 2024 Feb; 39(2):355-363. PubMed ID: 38145619
[TBL] [Abstract][Full Text] [Related]
19. Freeze-all, oocyte vitrification, or fresh embryo transfer? Lessons from an egg-sharing donation program.
Braga DP; Setti AS; Figueira RC; Azevedo Mde C; Iaconelli A; Lo Turco EG; Borges E
Fertil Steril; 2016 Sep; 106(3):615-22. PubMed ID: 27262501
[TBL] [Abstract][Full Text] [Related]
20. Slow oocyte freezing and thawing in couples with no sperm or an insufficient number of sperm on the day of in vitro fertilization.
Virant-Klun I; Bacer-Kermavner L; Tomazevic T; Vrtacnik-Bokal E
Reprod Biol Endocrinol; 2011 Feb; 9():19. PubMed ID: 21288363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
